AllianceBernstein
OLMA icon

AllianceBernstein’s Olema Pharmaceuticals OLMA Stock Holding History

AllianceBernstein’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Sell
57,840
-4,770
-8% -$106K ﹤0.01% 2175
2025
Q4 		$1.57M Sell
62,610
-14,050
-18% -$250K ﹤0.01% 2132
2025
Q3 		$751K Hold
76,660
– – ﹤0.01% 2478
2025
Q2 		$327K Buy
76,660
+32,040
+72% +$143K ﹤0.01% 2876
2025
Q1 		$168K Sell
44,620
-269,362
-86% -$1.35M ﹤0.01% 2966
2024
Q4 		$1.83M Buy
313,982
+137,319
+78% +$1.37M ﹤0.01% 2004
2024
Q3 		$2.11M Sell
176,663
-31,920
-15% -$408K ﹤0.01% 1932
2024
Q2 		$2.26M Buy
208,583
+183,493
+731% +$1.99M ﹤0.01% 1877
2024
Q1 		$284K Buy
25,090
+9,230
+58% +$119K ﹤0.01% 2816
2023
Q4 		$223K Buy
15,860
+4,960
+46% +$66.6K ﹤0.01% 2949
2023
Q3 		$135K Buy
+10,900
New +$111K ﹤0.01% 3023
2022
Q2 		– Sell
-12,400
Closed -$53K – 3340
2022
Q1 		$53K Sell
12,400
-3,300
-21% -$18.2K ﹤0.01% 3170
2021
Q4 		$147K Buy
15,700
+3,300
+27% +$68.4K ﹤0.01% 3137
2021
Q3 		$342K Hold
12,400
– – ﹤0.01% 2916
2021
Q2 		$347K Buy
+12,400
New +$353K ﹤0.01% 2969

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

AllianceBernstein's OLMA Position: Q1 2026 in Review

AllianceBernstein reduced its Olema Pharmaceuticals (OLMA) stake by 7.6% in Q1 2026, selling an estimated $106K and leaving 57,840 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2175.

AllianceBernstein first reported a position in OLMA in Q2 2021 and has held it in 15 quarters since. The position peaked at $2.26M in Q2 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • AllianceBernstein held 57,840 shares of Olema Pharmaceuticals worth $1.45M as of Q1 2026.
  • AllianceBernstein sold 4,770 Olema Pharmaceuticals shares in Q1 2026, an estimated $106K.
  • Olema Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2175 holding.
  • AllianceBernstein first reported a position in Olema Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • AllianceBernstein's Olema Pharmaceuticals position peaked at $2.26M in Q2 2024.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.